Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22205225 | 1.00 | TP53 (0.41) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL16052820 | 1.00 | TP53 (0.41) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL22205227 | 1.00 | TP53 (0.41) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2296713 | 1.00 | TP53 (0.41) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL14877096 | 1.00 | TP53 (0.41) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL9059526 | 0.92 | TP53 (0.47) | TP53SLC1A3SLC1A2SLC1A1TDP1 | |
| SCHEMBL9650094 | 0.85 | SLC1A3 (0.46) | TP53ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28163012 | 0.85 | SLC1A3 (0.42) | TP53SLC1A3SLC1A2SLC1A1TDP1 | |
| SCHEMBL28163011 | 0.85 | SLC1A3 (0.42) | TP53SLC1A3SLC1A2SLC1A1TDP1 | |
| SCHEMBL28163010 | 0.85 | SLC1A3 (0.42) | TP53SLC1A3SLC1A2SLC1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LTD (GB) | 2026-04-23 | — | — | US | claimed |
| EP-4714505-A2 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2026-03-25 | — | — | EP | claimed |
| US-11571479-B2 | Nutritional composition | TDELTAS (GB) | 2023-02-07 | — | — | US | claimed |
| US-20210015730-A1 | COMPOUND FOR USE IN PROTECTING SKIN | GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF OF HEALTH AND HUMAN SERVICES | 2021-01-21 | — | — | US | claimed |
| US-20200360517-A1 | NUTRITIONAL COMPOSITION | TDELTAS (GB) | 2020-11-19 | — | — | US | claimed |
| US-10660958-B2 | Nutritional composition | TDELTAS LIMITED (GB) | 2020-05-26 | — | — | US | claimed |
| EP-2968091-A1 | COMPOUND FOR USE IN PROTECTING SKIN | Tdeltas Limited (GB) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139599-A1 | COMPOUND FOR USE IN PROTECTING SKIN | TDELTAS LIMITED (GB) | 2014-09-18 | — | — | WO | claimed |
| US-20130102663-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2013-04-25 | — | — | US | claimed |
| EP-2539312-A1 | NUTRITIONAL COMPOSITION | Tdeltas Limited (GB) | 2013-01-02 | — | — | EP | claimed |
| WO-2011101171-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2011-08-25 | — | — | WO | claimed |
| US-20250275986-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | KETOSWISS AG (CH) | 2025-09-04 | — | — | US | disclosed |
| US-20250008999-A1 | Ketone Precursors And Methods Therefor | VDF FUTURECEUTICALS, INC. (US) | 2025-01-09 | — | — | US | disclosed |
| CN-118201608-A | Ketone precursors and methods thereof | VDF未来制剂股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4373483-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | KetoSwiss AG (CH) | 2024-05-29 | — | — | EP | disclosed |
| WO-2014071389-A1 | KETONE BODIES TO PROTECT TISSUES FROM DAMAGE BY IONIZING RADIATION | VEECH RICHARD L (US) | 2014-05-08 | — | — | WO | disclosed |
| WO-2013150153-A1 | KETONE BODIES AND KETONE BODY ESTERS FOR MAINTAINING OR IMPROVING MUSCLE POWER OUTPUT | TDELTAS LIMITED (GB) | 2013-10-10 | — | — | WO | disclosed |
| US-20130102663-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2013-04-25 | — | — | US | disclosed |
| EP-2539312-A1 | NUTRITIONAL COMPOSITION | Tdeltas Limited (GB) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011101171-A1 | NUTRITIONAL COMPOSITION | TDELTAS LIMITED (GB) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108442-A1 | COMPOUND FOR USE IN PROTECTING SKIN | CUTA, POT1, CETP | TP53 2897/4885ALDH1A1 1066/4885SLC1A3 317/4885 |
| US-20250275986-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | PKM, KCNMA1, KCNK18 | TP53 4748/4885ALDH1A1 996/4885SLC1A3 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.